Cargando…

Correction: Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin

Detalles Bibliográficos
Autor principal:	Colditz, Graham A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246169/ http://dx.doi.org/10.1186/bcr1786

Ejemplares similares

Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin
por: Colditz, Graham A
Publicado: (2007)

Postmenopausal estrogen and progestin effects on the serum proteome
por: Pitteri, Sharon J, et al.
Publicado: (2009)

The Proliferative Response to p27 Down-Regulation in Estrogen Plus Progestin Hormonal Therapy is Lost in Breast Tumors
por: Aupperlee, Mark D., et al.
Publicado: (2018)

Estrogens and Progestins Cooperatively Shift Breast Cancer Cell Metabolism
por: Ward, Ashley V., et al.
Publicado: (2022)

Estrogen–progestin replacement therapy: regulatory action needed
por: Pike, Malcolm C, et al.
Publicado: (2002)

Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report
por: Liang, Angela L., et al.
Publicado: (2021)

Hemodynamic and metabolic effects of estrogen plus progestin therapy in hypertensive postmenopausal women treated with an ACE-inhibitor or a diuretic
por: Posadzy-Malaczynska, Anna, et al.
Publicado: (2014)

Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments
por: Rajkumar, Lakshmanaswamy, et al.
Publicado: (2004)

Efficacy of Low-Dose Estrogen–Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis
por: Iwata, Masaru, et al.
Publicado: (2022)

Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review
por: Graziottin, Alessandra
Publicado: (2008)

Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen
por: Regidor, Pedro-Antonio, et al.
Publicado: (2023)

Author Correction: Triple SILAC identified progestin-independent and dependent PRA and PRB interacting partners in breast cancer
por: Pateetin, Prangwan, et al.
Publicado: (2021)

Effect of Alcohol Ingestion on Carcinogenesis by Synthetic Estrogen and Progestin in the Rat Liver
por: Yamagiwa, Kentaro, et al.
Publicado: (1991)

Is the Expression of the Components of the Carotid Matrix of Rats Influenced by Estrogen, Progestin and Tibolone?
por: Steiner, Marcelo Luis, et al.
Publicado: (2019)

Correction: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy
por: Munzone, Elisabetta, et al.
Publicado: (2006)

Correction to: MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α
por: Tang, Jianing, et al.
Publicado: (2022)

The progestin revolution 2: progestins are now a dominant player in the tight interlink between contraceptive protection and bleeding control—plus more
por: Shoupe, Donna
Publicado: (2023)

Correction: Dilated Thin-Walled Blood and Lymphatic Vessels in Human Endometrium: A Potential Role for VEGF-D in Progestin-Induced Break-Through Bleeding
por: Donoghue, Jacqueline F., et al.
Publicado: (2021)

Correction: Estrogenicity of Glabridin in Ishikawa Cells
por: Su Wei Poh, Melissa, et al.
Publicado: (2015)

Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study
por: Hoffman, Sarah R., et al.
Publicado: (2023)

Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis
por: Shao, Fengping, et al.
Publicado: (2023)

Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database
por: Hasegawa, Shiori, et al.
Publicado: (2017)

Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action
por: Matic, Marko, et al.
Publicado: (2019)

Modeling the Annual Costs of Postmenopausal Prevention Therapy: Raloxifene, Alendronate, or Estrogen-Progestin Therapy
por: Mullins, C. Daniel, et al.
Publicado: (2003)

Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha
por: Perkins, Meghan S., et al.
Publicado: (2022)

Correction to: Bone health in estrogen-free contraception
por: Hadji, P., et al.
Publicado: (2020)

Author Correction: Levonorgestrel correlates with less weight gain than other progestins during hormonal replacement therapy in Turner Syndrome patients
por: Mathez, Andréia Latanza Gomes, et al.
Publicado: (2020)

Correction: Bone marrow mesenchymal stem cells combined with estrogen synergistically promote endometrial regeneration and reverse EMT via Wnt/β-catenin signaling pathway
por: Yuan, Liwei, et al.
Publicado: (2022)

Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women
por: Dogiparthi, Anuradha, et al.
Publicado: (2010)

Correction: The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation
por: Zhu, J., et al.
Publicado: (2018)

Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study
por: Crandall, Carolyn, et al.
Publicado: (2005)

Correction: Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
por: Di Leva, Gianpiero, et al.
Publicado: (2013)

Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers Study
por: Lee, Eunjung, et al.
Publicado: (2014)

Correction: Effect of APOE and CD33 on Cognitive Decline
por: Hayden, Kathleen M., et al.
Publicado: (2015)

Correction: Estrogen Induces Global Reorganization of Chromatin Structure in Human Breast Cancer Cells
Publicado: (2015)

Correction to: Nirmatrelvir Plus Ritonavir: First Approval
por: Lamb, Yvette N.
Publicado: (2022)

Correction: Is It Necessary Managing Carnivores to Reverse the Decline of Endangered Prey Species? Insights from a Removal Experiment of Mesocarnivores to Benefit Demographic Parameters of the Pyrenean Capercaillie
por: Moreno-Opo, Rubén, et al.
Publicado: (2019)

Progestin and Nuclear Progestin Receptor Are Essential for Upregulation of Metalloproteinase in Zebrafish Preovulatory Follicles
por: Liu, Dong Teng, et al.
Publicado: (2018)

Modulatory Effect of Fermented Papaya Extracts on Mammary Gland Hyperplasia Induced by Estrogen and Progestin in Female Rats
por: You, Zhenqiang, et al.
Publicado: (2017)

Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ji5979vje8gmaaihpsh4k9p0ei